Nicholas J. Short, MD: Focus on TP53-Mutated ALL

September 17, 2025 By The ASCO Post Staff

Nicholas J. Short, MD, of The University of Texas MD Anderson Cancer Center, discusses TP53 abnormalities in acute lymphoblastic leukemia (ALL), which are uncommon in pediatric patients but may occur in 10% to 15% of adult patients with ALL. Dr. Short reviews recent research into their impact on outcomes, relapse, and the development of secondary cancers, and discusses novel therapeutic algorithms being employed. 

Related Content